Alphabet Replaces Verizon in Dow Jones Industrial Average 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
South Korea’s KOSPI Plunges as Apple Price Hikes and OpenAI IPO Delay Shake AI Chip Stocks 
Trump Team Rejects BBC Financial Data Request in $10B Lawsuit 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts 
Brazil Supreme Court Convicts Eduardo Bolsonaro Over U.S. Lobbying Efforts 
S&P Affirms Brazil’s BB Credit Rating with Stable Outlook Amid Fiscal Challenges 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
Gold Falls Below $4,000 as Strong Dollar and Fed Rate Hike Expectations Weigh on Prices 
Trump Administration Defends Anthropic AI Restrictions in Ongoing Federal Lawsuit 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
